辉瑞公布了强劲的收益，超出了预期，尽管金融公司减持了该公司的股份。 Pfizer reported strong earnings, beating estimates, despite financial firms reducing their holdings in the company.

金融咨询公司在第一季度减少了Pfizer的持有量,但生物制药公司报告每股收入高达0.78美元,击败估计数为0.20美元,销售额达10.3%。 Financial advisory firms have reduced their Pfizer holdings in the first quarter, but the biopharmaceutical company reported strong earnings of $0.78 per share, beating estimates by $0.20, with sales up 10.3%. Pfizer预测当年每股2.95美元的收入,并宣布到2027年将削减费用72亿美元。 Pfizer forecasts 2.95 earnings per share for the year and announced it would cut costs by $7.2 billion by 2027. 公司股票的评级是“Moderate Buy”,并每年支付7.0%的年红利。 The company's stock has a "Moderate Buy" rating and pays a 7.0% annualized dividend.